AlphaFold predicted structure
PSENEN · Q9NZ42

Mean pLDDT
92.6/ 100
Very high
101 residues
Confidence breakdown
- Very high(≥ 90)85%
- Confident(70–90)13%
- Low(50–70)2%
- Very low(< 50)0%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
presenilin enhancer, gamma-secretase subunit
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
COVID-19 research
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownFamilial hidradenitis suppurativa
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownPigmentary skin disorders
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedRare genetic inflammatory skin disorders
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownPrimary immunodeficiency or monogenic inflammatory bowel disease
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownhidradenitis suppurativa
neurodegenerative disease
desmoid tumor
Dowling-Degos disease
Alzheimer disease
neoplasm
fibromatosis
Parkinson disease
mathematical ability
breast cancer
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Gamma-secretase subunit PEN-2
Essential subunit of the gamma-secretase complex, an endoprotease complex that catalyzes the intramembrane cleavage of integral membrane proteins such as Notch receptors and APP (amyloid-beta precursor protein) (PubMed:12522139, PubMed:12679784, PubMed:12740439, PubMed:12763021, PubMed:24941111, PubMed:30598546, PubMed:30630874). The gamma-secretase complex plays a role in Notch and Wnt signaling cascades and regulation of downstream processes via its role in processing key regulatory proteins, and by regulating cytosolic CTNNB1 levels (Probable). PSENEN modulates both endoproteolysis of presenilin and gamma-secretase activity (PubMed:12522139, PubMed:12679784, PubMed:12740439, PubMed:12763021, PubMed:24941111). Besides its role in gamma-secretase complex, acts as a regulator of AMP-activated protein kinase (AMPK) activity in response to calorie restriction: binds metformin, an antidiabetic drug, promoting association with ATP6AP1, a subunit of the V-ATPase complex, leading to V-ATPase complex inhibition on lysosomes and AMPK activation via the AXIN1-STK11/LKB1 axis (By similarity)
PSENEN · Q9NZ42

Mean pLDDT
92.6/ 100
Very high
101 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0